NCI sells majority stake in Herbolistique to Yotta Capital Partners, Ouest Croissance
Reuters2026/07/30 10:47- NCI exited its majority stake in dietary supplements maker Laboratoires Herbolistique, selling to Yotta Capital Partners, Ouest Croissance, and other investors.
- NCI Dette Privée 1 provided mezzanine debt financing alongside the acquisition financing to support the company’s next growth phase.
- Herbolistique was founded in 2002 in La Verrie, France, producing plant-based natural supplements.
- NCI entered as majority shareholder in 2021; revenue rose to nearly EUR 15 million from EUR 10 million, headcount increased to 58.
- The deal marks the second investment by NCI’s private debt fund, following a transaction with Leader Group.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Extreme level of 8,500 emerges! Two top strategists raise S&P 500 target as strong earnings become key support
Despite facing a surge in US Treasury yields surpassing 5% and a slowdown in the AI sector, Wall Street institutions continue to raise their S&P 500 target prices, with the most bullish forecasts reaching up to 8,500 points.
BIG Impact invests in autoimmune diagnostics and drug discovery startup AOI Biosciences
LG Electronics Gains a Bull on Likely 3Q Earnings Beat -- Market Talk
2-Yr Benchmark Govt Yields - Germany vs Other Nations
Crypto prices
More
